发明名称 Polymer factor IX moiety conjugates
摘要 Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is polyethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
申请公布号 US9347054(B2) 申请公布日期 2016.05.24
申请号 US201314076116 申请日期 2013.11.08
申请人 Nektar Therapeutics 发明人 Bossard Mary J.;Stephenson Phillips Gayle
分类号 C07K14/745;C12N9/96;A61K47/48;C12N9/64 主分类号 C07K14/745
代理机构 McDermott Will & Emery LLP 代理人 Evans Susan T.;Wilson Mark A.;McDermott Will & Emery LLP
主权项 1. A composition comprising a plurality of polyethylene glycol (PEG)-Factor IX moiety conjugates, the conjugates comprising a branched polyethylene glycol covalently attached via a spacer moiety comprised of one or more atoms to a Factor IX moiety that is either Factor IX or Factor IXa, where at least about 85% of the polyethylene glycol-Factor IX moiety conjugates in the composition are monoPEGylated.
地址 San Francisco CA US
您可能感兴趣的专利